Ether

Ether

SCHEMBL511366

CCOCC.O=S(O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL5888547 0.97 CA1 (0.40)
Ether SCHEMBL11416717 0.97 CA1 (0.40)
Ether SCHEMBL1377128 0.85
Ether SCHEMBL15167076 0.82 ALDH1A1 (0.33)
Ether SCHEMBL4370775 0.81
Sulfurous Acid SCHEMBL10483923 0.76
Ether SCHEMBL135123 0.76
Ether SCHEMBL7435965 0.76 ALDH1A1 (0.50)
Ether SCHEMBL8349382 0.76 ALDH1A1 (0.50)
Ether SCHEMBL1766202 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105753742-B A kind of method for preparing perfluoroalkene ethers sulfonyl fluoride compound 山东东岳高分子材料有限公司 2018-03-09 CN disclosed
CN-105753742-B A kind of method for preparing perfluoroalkene ethers sulfonyl fluoride compound 山东东岳高分子材料有限公司 2018-03-09 CN disclosed
CN-104335382-B Substrate for organic electronic device 株式会社LG化学 2017-09-12 CN disclosed
CN-104205403-B Organic light emitting device and lighting apparatus 乐金显示有限公司 2016-11-16 CN disclosed
CN-103867968-B Lamp for the vehicles SL株式会社 2016-09-14 CN disclosed
CN-105753742-A Method for preparing perfluoro alkene ether sulfonyl fluoride compound 山东东岳高分子材料有限公司 2016-07-13 CN disclosed
CN-105753742-A Method for preparing perfluoro alkene ether sulfonyl fluoride compound 山东东岳高分子材料有限公司 2016-07-13 CN disclosed
US-20150353596-A1 17-Substituted Steroid Compounds HOLLIS-EDEN PHARMACEUTICALS, INC. 2015-12-10 US disclosed
US-8586770-B2 Unsaturated steroid compounds Harbor Therapeutics, Inc. (US) 2013-11-19 US disclosed
US-20120029260-A1 Screening and Treatment Method BIOVIE INC. 2012-02-02 US disclosed
WO-2007030124-A2 TREATMENT SCREENING METHODS HOLLIS-EDEN PHARMACEUTICALS, INC (US) 2007-03-15 WO disclosed
US-20070053832-A1 Drug product and process for making BIOVIE INC. 2007-03-08 US disclosed
US-20070014719-A1 Steroid analogs and characterization and treatment methods BIOVIE INC. 2007-01-18 US disclosed
WO-2006110172-A2 STEROID ANALOGS AND CHARACTERIZATION AND TREATMENT METHODS HOLLIS-EDEN PHARMACEUTICALS.INC. (US) 2006-10-19 WO disclosed
US-20060088473-A1 Treatment screening methods BIOVIE INC. 2006-04-27 US disclosed
US-20060073099-A1 Treatment screening methods BIOVIE INC. 2006-04-06 US disclosed
EP-1539183-A1 THERAPEUTIC TREATMENT METHODS Hollis-Eden Pharmaceuticals Inc. (US) 2005-06-15 EP disclosed
US-20050101581-A1 Therapeutic treatment methods 2 BIOVIE INC. 2005-05-12 US disclosed
US-20040138187-A1 Therapeutic treatment methods BIOVIE INC. 2004-07-15 US disclosed
WO-2004019953-A1 THERAPEUTIC TREATMENT METHODS HOLLIS-EDEN PHARMACEUTICALS, INC. (US) 2004-03-11 WO disclosed